| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1311471B1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1041880A4 A delivery of arginine to cause beneficial effects |
| 04/12/2006 | EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 04/12/2006 | EP1009387B1 Stabilized sustained release tramadol formulations |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0843726B1 Opioid antagonists and methods of their use |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759116A Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 04/12/2006 | CN1759112A Benzimidazole derivatives and their use for modulating the GABA- SB A /SB receptor complex |
| 04/12/2006 | CN1759111A Imidazol-4-yl-ethynyl-pyridine derivatives |
| 04/12/2006 | CN1759099A Substituted aniline derivatives |
| 04/12/2006 | CN1758922A Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 04/12/2006 | CN1758912A Therapeutic agents for drug/substance dependence |
| 04/12/2006 | CN1757635A 4-hydroxy valeramide compounds, prepn. method and use thereof |
| 04/12/2006 | CN1757409A Recipe of Wanshou capsule, and health-care function |
| 04/12/2006 | CN1757390A Obtundent-Tilidin hydrochloride preparation |
| 04/12/2006 | CN1250732C 病毒株 Strains |
| 04/12/2006 | CN1250731C Packaging of positive-strand RNA virus replicon particles |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250572C Anti-body capable to selectively detect prion PrPsc isoforms |
| 04/12/2006 | CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/12/2006 | CN1250295C Magnetism and drug combined type fragrant baldric for avoiding plague |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250278C Oral medicine for treating dementia and feeblemindedness |
| 04/12/2006 | CN1250274C Medicine for abstinence of drugs and rehabilitation and preparing process thereof |
| 04/12/2006 | CN1250271C Zhenge lozenge having sobering, liver protection and stomach protection health function |
| 04/12/2006 | CN1250248C Analgesic |
| 04/12/2006 | CN1250241C Application of persimmon leaf extract in the preparation of medicine for preventing and treating nerve function retrograde affection |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/12/2006 | CN1250222C Praziquantel composition for treating diseases due to sarcocystis, neospora, toxoplasma and isospora |
| 04/12/2006 | CN1250220C Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
| 04/12/2006 | CN1250218C Use of angiotensin II antagonists |
| 04/12/2006 | CN1250215C Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/12/2006 | CN1250214C Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/12/2006 | CN1250213C Carbamate compounds for use in preventing or treating nevous pain and cluster and migraine headache-associated pain |
| 04/12/2006 | CN1250208C Fluoxetine enteric coated tablet |
| 04/12/2006 | CN1250121C Compound tobacco addict controlling plaster and its preparation method |
| 04/11/2006 | US7026516 Compounds with high monoamine transporter affinity |
| 04/11/2006 | US7026514 Compounds used to treat alcoholism |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026475 carbapenem derivatives with an antibacterial activity |
| 04/11/2006 | US7026469 Compositions and methods of double-targeting virus infections and cancer cells |
| 04/11/2006 | US7026361 Dispersion stability; forming protective colloid; bioavailability; hypotensive agents, oral diseases |
| 04/11/2006 | US7026358 Oral general anesthetics and metabolitically resistant anticonvulsants |
| 04/11/2006 | US7026357 Diphenylurea compounds |
| 04/11/2006 | US7026351 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026332 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder, specific social phobia, premenstrual dysphoric disorder, and other psychological disorders |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026320 Serotonergic agents |
| 04/11/2006 | US7026318 Compounds exhibiting X-type sPLA2 inhibiting effect |
| 04/11/2006 | US7026317 bind to corticotropin releasing factor (CRF) receptors; psychological disorders; anxiety-related disorders; central nervous system disorders |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | US7026311 Dibenzodiazepine derivatives, their preparation and use |
| 04/11/2006 | US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/11/2006 | US7026304 especially for blocking rocuronium, vecuronium, pancuronium and rapacuronium salts; kits. |
| 04/11/2006 | US7026297 Neuroprotective agents |
| 04/11/2006 | US7026280 Polypeptides; nervous system, brain disorders |
| 04/11/2006 | US7026129 IG lambda biopolymer markers predictive of Alzheimers disease |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | US7025515 Bit mask generation system |
| 04/11/2006 | CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 04/11/2006 | CA2282840C S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 04/11/2006 | CA2281702C (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/11/2006 | CA2195759C Tetrahydropyridinylmethyl derivatives of pyrrolo[2,3-b]pyridine |
| 04/06/2006 | WO2006037043A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 04/06/2006 | WO2006036874A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006036015A2 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 04/06/2006 | WO2006035936A1 Par-2 antagonists |
| 04/06/2006 | WO2006035900A1 Coenzyme q10-containing emulsified composition |
| 04/06/2006 | WO2006035702A1 C-peptide specific binding molecule and use thereof |
| 04/06/2006 | WO2006035622A1 In vivo nerve nutrition factor producing method using alternating high potential and in vivo nerve nutrition factor producing device |
| 04/06/2006 | WO2006035414A2 Carbidopa and levodopa dispersible tablets |
| 04/06/2006 | WO2006035308A1 Histamine-3 receptor antagonists |
| 04/06/2006 | WO2006034965A1 Process for the purification of ziprasidone |
| 04/06/2006 | WO2006034964A1 Process for preparing ziprasidone |
| 04/06/2006 | WO2006034873A1 METHODS FOR THE GENERATION OF HEPATOCYTE-LIKE CELLS FROM HUMAN BLASTOCYST-DERIVED STEM (hBs) |
| 04/06/2006 | WO2006013457A3 Gad2 gene for possible treatment of nervous system disorders |
| 04/06/2006 | WO2006001866A3 Crystalline forms of n-desmethylclozapine |
| 04/06/2006 | WO2005041937A3 Controlled release sterile injectable aripiprazole formulation and method |
| 04/06/2006 | US20060074253 Process for the preparation of citalopram |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074240 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline |
| 04/06/2006 | US20060074238 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |